Balance Sheet Breakdown: ProQR Therapeutics N.V (PRQR)’s Debt-to-Equity and Long-Term Debt/Eq Ratios

Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

After finishing at $3.47 in the prior trading day, ProQR Therapeutics N.V (NASDAQ: PRQR) closed at $3.54, up 2.02%. In other words, the price has increased by $2.02 from its previous closing price. On the day, 0.53 million shares were traded. PRQR stock price reached its highest trading level at $3.6699 during the session, while it also had its lowest trading level at $3.4501.

Ratios:

Our goal is to gain a better understanding of PRQR by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.33 and its Current Ratio is at 2.33. In the meantime, Its Debt-to-Equity ratio is 0.63 whereas as Long-Term Debt/Eq ratio is at 0.46.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Raymond James on October 29, 2024, Upgraded its rating to Strong Buy and sets its target price to $14 from $6 previously.

On November 08, 2023, Chardan Capital Markets Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $2.

JMP Securities Upgraded its Mkt Perform to Mkt Outperform on March 30, 2023, whereas the target price for the stock was revised from $1.50 to $5.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PRQR now has a Market Capitalization of 374910784 and an Enterprise Value of 217155168. For the stock, the TTM Price-to-Sale (P/S) ratio is 18.86 while its Price-to-Book (P/B) ratio in mrq is 10.37. Its current Enterprise Value per Revenue stands at 11.811 whereas that against EBITDA is -7.592.

Stock Price History:

Over the past 52 weeks, PRQR has reached a high of $4.62, while it has fallen to a 52-week low of $1.61. The 50-Day Moving Average of the stock is 10.96%, while the 200-Day Moving Average is calculated to be 56.12%.

Shares Statistics:

The stock has traded on average 1.40M shares per day over the past 3-months and 339270 shares per day over the last 10 days, according to various share statistics. A total of 81.68M shares are outstanding, with a floating share count of 73.25M. Insiders hold about 29.02% of the company’s shares, while institutions hold 17.68% stake in the company. Shares short for PRQR as of 1731628800 were 413765 with a Short Ratio of 0.30, compared to 1728950400 on 133298. Therefore, it implies a Short% of Shares Outstanding of 413765 and a Short% of Float of 0.5.

Most Popular